S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
Bear market expert makes new prediction (Ad)
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
Bear market expert makes new prediction (Ad)
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
Bear market expert makes new prediction (Ad)
Is Braze, Inc Ready To Rocket Higher? 
Many electric vehicles to lose big tax credit with new rules
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
Bear market expert makes new prediction (Ad)
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
Bear market expert makes new prediction (Ad)
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
Bear market expert makes new prediction (Ad)
Is Braze, Inc Ready To Rocket Higher? 
Many electric vehicles to lose big tax credit with new rules
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
Bear market expert makes new prediction (Ad)
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
Bear market expert makes new prediction (Ad)
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
Bear market expert makes new prediction (Ad)
Is Braze, Inc Ready To Rocket Higher? 
Many electric vehicles to lose big tax credit with new rules
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
Bear market expert makes new prediction (Ad)
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
Bear market expert makes new prediction (Ad)
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
Bear market expert makes new prediction (Ad)
Is Braze, Inc Ready To Rocket Higher? 
Many electric vehicles to lose big tax credit with new rules
NASDAQ:APLT

Applied Therapeutics - APLT Stock Forecast, Price & News

$0.81
+0.01 (+1.25%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.76
$0.85
50-Day Range
$0.80
$1.21
52-Week Range
$0.50
$2.73
Volume
202,050 shs
Average Volume
292,727 shs
Market Capitalization
$39.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.13

Applied Therapeutics MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
1,184.3% Upside
$10.42 Price Target
Short Interest
Healthy
0.87% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.88
Upright™ Environmental Score
News Sentiment
0.94mentions of Applied Therapeutics in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$19,950 Sold Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.55 out of 5 stars

Medical Sector

116th out of 1,004 stocks

Pharmaceutical Preparations Industry

44th out of 489 stocks


APLT stock logo

About Applied Therapeutics (NASDAQ:APLT) Stock

Applied Therapeutics, Inc. is a clinical-stage biopharmaceutical company which engages in the development of a pipeline of novel products. It is targeting treatments for central nervous system rare diseases and diabetic complications. The company was founded by Shoshana Shendelman on January 20, 2016 and is headquartered in New York, NY.

Receive APLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

APLT Stock News Headlines

"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.
"Prepare for Five Years of Famine"
Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast.
Applied Therapeutics
Applied Therapeutics, Inc. (APLT)
Recap: Applied Therapeutics Q2 Earnings
Nasdaq Jumps Over 100 Points; Applied Therapeutics Shares Plummet
See More Headlines
Receive APLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Applied Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

APLT Company Calendar

Last Earnings
3/23/2023
Today
4/01/2023
Next Earnings (Estimated)
5/11/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:APLT
Fax
N/A
Employees
34
Year Founded
2017

Price Target and Rating

Average Stock Price Forecast
$10.42
High Stock Price Forecast
$23.00
Low Stock Price Forecast
$2.25
Forecasted Upside/Downside
+408.6%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
2 Analysts

Profitability

Net Income
$-82,510,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.08 per share

Miscellaneous

Free Float
39,935,000
Market Cap
$39.02 million
Optionable
Not Optionable
Beta
1.90

Social Links


Key Executives

  • Shoshana ShendelmanShoshana Shendelman
    Chairman, President, CEO & Secretary
  • Steven Ortega
    Chief Financial & Accounting Officer
  • Riccardo PerfettiRiccardo Perfetti
    Chief Medical Officer
  • Adam Hansard
    Chief Commercial Officer













APLT Stock - Frequently Asked Questions

Should I buy or sell Applied Therapeutics stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Applied Therapeutics in the last twelve months. There are currently 1 hold rating and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" APLT shares.
View APLT analyst ratings
or view top-rated stocks.

What is Applied Therapeutics' stock price forecast for 2023?

2 equities research analysts have issued twelve-month target prices for Applied Therapeutics' shares. Their APLT share price forecasts range from $2.25 to $23.00. On average, they predict the company's share price to reach $10.42 in the next year. This suggests a possible upside of 1,184.3% from the stock's current price.
View analysts price targets for APLT
or view top-rated stocks among Wall Street analysts.

How have APLT shares performed in 2023?

Applied Therapeutics' stock was trading at $0.76 at the beginning of the year. Since then, APLT shares have increased by 6.7% and is now trading at $0.8111.
View the best growth stocks for 2023 here
.

Are investors shorting Applied Therapeutics?

Applied Therapeutics saw a drop in short interest in the month of March. As of March 15th, there was short interest totaling 417,000 shares, a drop of 17.3% from the February 28th total of 504,100 shares. Based on an average daily volume of 279,900 shares, the days-to-cover ratio is presently 1.5 days.
View Applied Therapeutics' Short Interest
.

When is Applied Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 11th 2023.
View our APLT earnings forecast
.

How were Applied Therapeutics' earnings last quarter?

Applied Therapeutics, Inc. (NASDAQ:APLT) released its quarterly earnings results on Thursday, March, 23rd. The company reported ($0.16) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Applied Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Applied Therapeutics investors own include Enterprise Products Partners (EPD), Pfizer (PFE), Advanced Micro Devices (AMD), Energy Transfer (ET), Micron Technology (MU), NVIDIA (NVDA), Verizon Communications (VZ), AbbVie (ABBV), Walt Disney (DIS) and Raytheon Technologies (RTX).

When did Applied Therapeutics IPO?

(APLT) raised $60 million in an initial public offering (IPO) on the week of May 13th 2019. The company issued 4,000,000 shares at a price of $14.00-$16.00 per share. Citigroup, Cowen and UBS Investment Bank acted as the underwriters for the IPO and Baird was co-manager.

What is Applied Therapeutics' stock symbol?

Applied Therapeutics trades on the NASDAQ under the ticker symbol "APLT."

How do I buy shares of Applied Therapeutics?

Shares of APLT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Applied Therapeutics' stock price today?

One share of APLT stock can currently be purchased for approximately $0.81.

How much money does Applied Therapeutics make?

Applied Therapeutics (NASDAQ:APLT) has a market capitalization of $39.02 million. The company earns $-82,510,000.00 in net income (profit) each year or ($2.40) on an earnings per share basis.

How can I contact Applied Therapeutics?

Applied Therapeutics' mailing address is 340 MADISON AVENUE 19TH FLOOR, NEW YORK NY, 10173. The official website for the company is www.appliedtherapeutics.com. The company can be reached via phone at (212) 220-9226 or via email at maeve@argotpartners.com.

This page (NASDAQ:APLT) was last updated on 4/1/2023 by MarketBeat.com Staff